Nuformix 

€0
0
+€0+0% Wednesday 15:31

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23JulExpected
Q3 2021
Next
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1RT.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Nuformix plc, together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. The company develops NXP001, which is in the Phase 1 stage for use in oncology supportive care; NXP002, which is in the pre-clinical stage for the treatment of idiopathic pulmonary fibrosis; and NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology. It has a licensing agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc is based in London, the United Kingdom.
Show more...
CEO
Dr. Daniel John Gooding
Employees
3
Country
United Kingdom
ISIN
GB00BYW79Y38

Listings

0 Comments

Share your thoughts

FAQ

What is Nuformix stock price today?
The current price of 1RT.STU is €0 EUR — it has increased by +0% in the past 24 hours. Watch Nuformix stock price performance more closely on the chart.
What is Nuformix stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nuformix stocks are traded under the ticker 1RT.STU.
Is Nuformix stock price growing?
1RT.STU stock has risen by +0% compared to the previous week, the month change is a -0% fall, over the last year Nuformix has showed a -50% decrease.
When is the next Nuformix earnings date?
Nuformix is going to release the next earnings report on July 23, 2026.
What were Nuformix earnings last quarter?
1RT.STU earnings for the last quarter are 0 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Nuformix have?
As of April 30, 2026, the company has 3 employees.
In which sector is Nuformix located?
Nuformix operates in the Health & Wellness sector.
When did Nuformix complete a stock split?
Nuformix has not had any recent stock splits.
Where is Nuformix headquartered?
Nuformix is headquartered in London, United Kingdom.